Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million
04/03/2026 21:01
Mar 04 (Reuters) - Aquestive Therapeutics, Inc. Q4 revenue USD 13.015 million vs. IBES estimate USD 13.3 million. Q4 pretax profit USD -31.86 million Q4 income from operations USD -28.839 million Q4 adjusted EBITDA USD -27.334 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million